Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 34,000 shares at $150.02 ($5.1M) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $5.1M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.02 | 5,081 | $762K | 14.8% |
| 2 | $150.02 | 5,081 | $762K | 14.8% |
| 3 | $150.87 | 5,496 | $829K | 16.1% |
| 4 | $150.87 | 5,496 | $829K | 16.1% |
| 5 | $151.68 | 2,295 | $348K | 6.8% |
| 6 | $151.68 | 2,295 |
| $348K |
| 6.8% |
| 7 | $152.96 | 2,410 | $369K | 7.2% |
| 8 | $152.96 | 2,410 | $369K | 7.2% |
| 9 | $153.58 | 1,718 | $264K | 5.1% |
| 10 | $153.58 | 1,718 | $264K | 5.1% |
| Total | $151.30 avg | 34,000 | $5.1M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |